Page last updated: 2024-10-27

flucytosine and Opportunistic Infections

flucytosine has been researched along with Opportunistic Infections in 47 studies

Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.

Opportunistic Infections: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.

Research Excerpts

ExcerptRelevanceReference
"To compare the efficacy of fluconazole with amphotericin B plus flucytosine in the treatment of cryptococcal meningitis."9.06Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. ( Chan, LS; Larsen, RA; Leal, MA, 1990)
"To compare the efficacy of fluconazole with amphotericin B plus flucytosine in the treatment of cryptococcal meningitis."5.06Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. ( Chan, LS; Larsen, RA; Leal, MA, 1990)
"A case of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) associated with pulmonary cryptococcosis which was successfully treated with fluconazole (FCZ) and flucytosine (5-FC) is described."4.78[A case report--pulmonary cryptococcosis associated with systemic lupus erythematosus and review of 44 cases in Japan]. ( Kano, S; Minato, N; Saito, K; Saito, T; Saku, N; Sato, M; Suzuki, N; Takeda, A, 1993)
"We present six cases of fusariosis caused by Fusarium solani that were diagnosed over a three-year period in 166 adult patients undergoing chemotherapy for acute leukemia."4.77Diagnosis and successful treatment of fusariosis in the compromised host. ( Hoagland, M; Hood, AF; Jett-Goheen, M; Junkins, JM; Karp, JE; Merz, WG, 1988)
" Flucytosine (5FC) has shown synergistic effect with AmB for treatment of some fungal infections, such as cryptococcosis, but again, its price is a limitation for its use in many regions."3.96Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and ( Agreda-Mellon, D; de Oliveira, HC; García-Cambero, JP; Lucio, J; Mendes-Giannini, MJS; Rossi, SA; Zaragoza, O, 2020)
"We report two cases of cryptococcosis in patients with Waldenstrom's macroglobulinaemia and chronic lymphocytic leukaemia that responded to prolonged therapy with systemic amphotericin and flucytosine."3.70Cryptococcosis: an unusual opportunistic infection complicating B cell lymphoproliferative disorders. ( Colbridge, M; Keenan, F; Melzer, M; Ong, EL; Stainsby, D, 1998)
"We report the treatment of cerebral aspergillosis with amphotericin B, flucytosine, surgery, and liposomal amphotericin B (L-AmB) after a liver transplant."3.68Treatment of cerebral aspergillosis after liver transplantation. ( Berciano, J; Casafont, F; Fábrega, E; Fariñas, MC; Polo, JM; Salesa, R; Vázquez, A, 1992)
"Hydrocephalus is the most common neurosurgical complication of cerebral cryptococcosis."2.38[Neurological form of cryptococcosis. Apropos of 2 atypical cases in non HIV-infected patients]. ( Donnet, A; Durand, JM; Graziani, N; Grisoli, F; Harlé, JR; Touta, A, 1993)
"This aplastic anemia failed to respond first to an antithymocyte globulin and steroid treatment and then to cyclosporine A."2.38Cunninghamella bertholletiae: an uncommon agent of opportunistic fungal infection. Case report and review. ( Bergerat, JP; Dufour, P; Herbrecht, R; Koenig, H; Liu, KL; Maloisel, F; Marcellin, L; Oberling, F; Waller, J; Weber, JC, 1991)
"Systemic candidiasis is a disease of increasing incidence and proportions, which appears to be associated with the advances in modern medicine."2.38Systemic candidiasis. ( Ray, TL, 1989)
"A 60-year-old man with acute myeloid leukemia (AML) presented with multifocal muscle abscesses of the legs."1.51Multifocal muscle candidiasis of the legs in a patient with acute myeloid leukemia: A case report. ( Li, L; Yang, M; Yang, X; Yi, P; Zhang, Y, 2019)
"Cryptococcal meningitis is a critical illness affecting 0."1.48Favorable Evolution of Cryptococcal Meningitis in the Context of Flucytosine Resistance. ( Bedouch, P; Brion, JP; Camara, B; Claustre, J; Pison, C; Quétant, S, 2018)
" Clinical improvement was apparent for 13 months during steroid therapy until the slow taper reached a dosage of 20 mg/day."1.31Cryptococcal infection in sarcoidosis. ( Gibson, LE; Kist, JM; Mehrany, K, 2002)
"Mucormycosis is an opportunistic infection occurring in the severely immunocompromised patient."1.30Successful cure of an extensive burn injury complicated with mucor wound sepsis. ( Tang, D; Wang, W, 1998)
"Cryptococcosis is more frequently observed since the appearance of the acquired immunodeficiency syndrome (AIDS)."1.28[Cryptococcosis: presentation of 26 cases]. ( Azón, A; Gatell, JM; González-Clemente, JM; Mallolas, J; Mensa, J; Miró, JM; Moreno, A; Pedrol, E; Soriano, E, 1992)
"Patients with AIDS were younger and predominantly male; they had a shorter duration of prior illness, higher initial serum cryptococcal antigen titers, and lower initial cerebrospinal fluid white blood cell counts than those with neoplastic disease."1.28Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease. ( Armstrong, D; Blevins, A; Cirrincione, C; White, M, 1992)
"Fluconazole has shown effectiveness in maintenance therapy, being not be possible to evaluate it as an acute phase therapy because the low number of cases in which it was studied."1.28[Cryptococcosis in AIDS patients: a study of 19 cases]. ( Adrados de Llano, M; García Aguado, C; Gazapo Carretero, E; González Lahoz, JM; Martínez Blanco, ML; Verdejo Ortes, J, 1992)
" Because amphotericin B nephrotoxicity was suspected, further intravenous administration was stopped after a cumulative dosage of 2 g."1.28[Cryptococcal meningitis in AIDS: successful long-term prophylaxis with fluconazole]. ( Glück, T; Weber, P; Wiedmann, KH, 1991)
"Treatment with amphotericin B, flucytosine and high doses of fluconazole was followed by clinical improvement, although CSF pleocytosis remained."1.28First report of chronic meningitis caused by Trichosporon beigelii. ( Boogaerts, M; Marcelis, L; Surmont, I; Verbist, L; Vergauwen, B; Verhoef, G, 1990)
"Treatment with amphotericin B and flucytosine was very effective, there being no more growth of fungi in cultures in most cases."1.28Cryptococcosis in AIDS patients: observations concerning CNS involvement. ( de Matos-Marques, B; Pohle, HD; Rögler, G; Seibold, M; Sixt, C; Staib, F; Weinke, T, 1989)
"Treatment with amphotericin B, 5-fluorocytosine, and splenectomy proved successful."1.27Successful treatment of disseminated Trichosporon beigelii (cutaneum) infection with associated splenic involvement. ( Bhansali, S; Crane, L; Karanes, C; Kiel, R; Palutke, W; Ratanatharathorn, V, 1986)

Research

Studies (47)

TimeframeStudies, this research(%)All Research%
pre-199010 (21.28)18.7374
1990's23 (48.94)18.2507
2000's8 (17.02)29.6817
2010's3 (6.38)24.3611
2020's3 (6.38)2.80

Authors

AuthorsStudies
Barrett, K1
Tavakoli, S1
McGinity, M1
Gilbert, A1
Rossi, SA1
de Oliveira, HC1
Agreda-Mellon, D1
Lucio, J1
Mendes-Giannini, MJS1
García-Cambero, JP1
Zaragoza, O1
Cunha Pereira, T2
Rb-Silva, R2
Félix Soares, R2
Domingues, N2
Mariz, J2
Yi, P1
Yang, X1
Yang, M1
Zhang, Y1
Li, L1
Claustre, J1
Brion, JP1
Quétant, S1
Bedouch, P1
Pison, C1
Camara, B1
Araujo Ribeiro, M1
Alastruey-Izquierdo, A1
Gomez-Lopez, A1
Rodriguez-Tudela, JL1
Cuenca-Estrella, M1
Kontoyiannis, DP1
Mehrany, K1
Kist, JM1
Gibson, LE1
Polak, A1
Kendirli, T1
Ciftçi, E1
Ince, E1
Oncel, S1
Dalgiç, N1
Güriz, H1
Unal, E1
Dogru, U1
Cancelli, I1
Merlino, G1
Serafini, A1
Valente, M1
Gigli, GL1
Choi, JD1
Powers, CJ1
Vredenburgh, JJ1
Friedman, AH1
Sampson, JH1
Denning, DW1
Donnet, A1
Graziani, N1
Harlé, JR1
Durand, JM1
Touta, A1
Grisoli, F1
St Georgiev, V1
Akiba, Y1
Osanai, S1
Nakano, H1
Matsumoto, H1
Onodera, S1
Sato, M1
Saku, N1
Takeda, A1
Suzuki, N1
Saito, T1
Minato, N1
Saito, K1
Kano, S1
Benard, G1
Gryschek, RC1
Duarte, AJ1
Shikanai-Yasuda, MA1
Rex, JH1
Walsh, TJ1
Anaissie, EJ1
Melzer, M1
Colbridge, M1
Keenan, F1
Stainsby, D1
Ong, EL1
Tang, D1
Wang, W1
Fouassier, M1
Joly, D1
Cambon, M1
Peigue-Lafeuille, H1
Condat, P1
Cawley, MJ1
Braxton, GR1
Haith, LR1
Reilly, KJ1
Guilday, RE1
Patton, ML1
Ellepola, AN1
Samaranayake, LP1
de Gans, J1
Portegies, P1
Tiessens, G1
Eeftinck Schattenkerk, JK1
van Boxtel, CJ1
van Ketel, RJ1
Stam, J1
Eloy, O1
Joly, V1
Ghnassia, JC1
Carbon, C1
Yeni, P1
Sudduth, EJ1
Crumbley, AJ1
Farrar, WE1
Polo, JM1
Fábrega, E1
Casafont, F1
Fariñas, MC1
Salesa, R1
Vázquez, A1
Berciano, J1
Pedrol, E1
Mallolas, J1
González-Clemente, JM1
Miró, JM1
Azón, A1
Gatell, JM1
Moreno, A1
Mensa, J1
Soriano, E1
White, M1
Cirrincione, C1
Blevins, A1
Armstrong, D1
Gazapo Carretero, E1
García Aguado, C1
Adrados de Llano, M1
Martínez Blanco, ML1
Verdejo Ortes, J1
González Lahoz, JM1
Glück, T1
Weber, P1
Wiedmann, KH1
Maloisel, F1
Dufour, P1
Waller, J1
Herbrecht, R1
Marcellin, L1
Koenig, H1
Liu, KL1
Weber, JC1
Bergerat, JP1
Oberling, F1
Larsen, RA1
Leal, MA1
Chan, LS1
ter Borg, F1
Kuijper, EJ1
van der Lelie, H1
Surmont, I1
Vergauwen, B1
Marcelis, L1
Verbist, L1
Verhoef, G1
Boogaerts, M1
Kofler, H1
Fritsch, P1
Radentz, WH1
Ray, TL1
Weinke, T1
Rögler, G1
Sixt, C1
de Matos-Marques, B1
Pohle, HD1
Staib, F1
Seibold, M1
Merz, WG1
Karp, JE1
Hoagland, M1
Jett-Goheen, M1
Junkins, JM1
Hood, AF1
Orefice, G1
Carrieri, PB1
Vecchione, V1
Chirianni, A1
Tullio-Cataldo, P1
Striano, S1
Bhansali, S1
Karanes, C1
Palutke, W1
Crane, L1
Kiel, R1
Ratanatharathorn, V1
Desai, MH1
Herndon, DN1
Abston, S1
Flynn, P1
Feldman, S1
Lenoir, A1
Pearson, T1
Johnson, FL1
Etcubanas, E1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Markers of Pulmonary Dysbiosis Associated With Exacerbation in Patients Followed for Cystic Fibrosis[NCT03569904]30 participants (Anticipated)Observational2018-10-02Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

17 reviews available for flucytosine and Opportunistic Infections

ArticleYear
Invasive mycoses: strategies for effective management.
    The American journal of medicine, 2012, Volume: 125, Issue:1 Suppl

    Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Antifungal Agents; Antineoplastic Agents; Asparta

2012
[Flucytosine - a classical partner for combination therapy].
    Mycoses, 2002, Volume: 45 Suppl 3

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Mitosporic Fungi;

2002
Treatment of invasive aspergillosis.
    The Journal of infection, 1994, Volume: 28 Suppl 1

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Aspergillosis; Cholesterol Esters; Drug Carri

1994
[Neurological form of cryptococcosis. Apropos of 2 atypical cases in non HIV-infected patients].
    Revue neurologique, 1993, Volume: 149, Issue:5

    Topics: Adolescent; Adult; Agammaglobulinemia; Amphotericin B; Brain Abscess; Brain Diseases; Cryptococcosis

1993
Opportunistic/nosocomial infections. Treatment and developmental therapeutics. I. Cryptococcosis.
    Medicinal research reviews, 1993, Volume: 13, Issue:4

    Topics: Amphotericin B; Animals; Cross Infection; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Com

1993
[A case report--pulmonary cryptococcosis associated with systemic lupus erythematosus and review of 44 cases in Japan].
    Ryumachi. [Rheumatism], 1993, Volume: 33, Issue:1

    Topics: Arthritis, Rheumatoid; Cryptococcosis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine;

1993
Fungal infections in iatrogenically compromised hosts.
    Advances in internal medicine, 1998, Volume: 43

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Catheters, Indwelling; Diagno

1998
[Geotrichum capitatum infection in a neutropenic patient. Apropos of a case and review of the literature].
    La Revue de medecine interne, 1998, Volume: 19, Issue:6

    Topics: Acute Disease; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Drug Combinations; Fatal Ou

1998
Trichosporon beigelii infection: experience in a regional burn center.
    Burns : journal of the International Society for Burn Injuries, 2000, Volume: 26, Issue:5

    Topics: Adult; Amphotericin B; Antifungal Agents; Burns; Catheters, Indwelling; Drug Resistance, Microbial;

2000
Oral candidal infections and antimycotics.
    Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists, 2000, Volume: 11, Issue:2

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agen

2000
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
    Presse medicale (Paris, France : 1983), 1992, May-30, Volume: 21, Issue:20

    Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Th

1992
Phaeohyphomycosis due to Exophiala species: clinical spectrum of disease in humans.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 15, Issue:4

    Topics: Adult; Amphotericin B; Combined Modality Therapy; Drug Administration Schedule; Drug Therapy, Combin

1992
Cunninghamella bertholletiae: an uncommon agent of opportunistic fungal infection. Case report and review.
    Nouvelle revue francaise d'hematologie, 1991, Volume: 33, Issue:4

    Topics: Adult; Amphotericin B; Anemia, Aplastic; Flucytosine; Humans; Immunocompromised Host; Lung Diseases,

1991
Cryptococcosis in the immunocompromised host.
    Current problems in dermatology, 1989, Volume: 18

    Topics: Amphotericin B; Cryptococcosis; Flucytosine; Humans; Immunologic Deficiency Syndromes; Male; Middle

1989
Opportunistic fungal infections in immunocompromised hosts.
    Journal of the American Academy of Dermatology, 1989, Volume: 20, Issue:6

    Topics: Amphotericin B; Dermatomycoses; Flucytosine; Humans; Immunosuppression Therapy; Ketoconazole; Opport

1989
Systemic candidiasis.
    Dermatologic clinics, 1989, Volume: 7, Issue:2

    Topics: Amphotericin B; Candidiasis; Flucytosine; Humans; Immune Tolerance; Ketoconazole; Neoplasms; Opportu

1989
Diagnosis and successful treatment of fusariosis in the compromised host.
    The Journal of infectious diseases, 1988, Volume: 158, Issue:5

    Topics: Adult; Amphotericin B; Female; Flucytosine; Fusarium; Humans; Immune Tolerance; Leukemia; Leukemia,

1988

Trials

2 trials available for flucytosine and Opportunistic Infections

ArticleYear
Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis.
    AIDS (London, England), 1992, Volume: 6, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combinat

1992
Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.
    Annals of internal medicine, 1990, Aug-01, Volume: 113, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans;

1990

Other Studies

28 other studies available for flucytosine and Opportunistic Infections

ArticleYear
Intracranial Epstein-Barr virus-associated smooth muscle tumor with superimposed cryptococcal infection: A case report.
    Medicine, 2022, Mar-04, Volume: 101, Issue:9

    Topics: Adult; Amphotericin B; Antiretroviral Therapy, Highly Active; Cryptococcus neoformans; Epstein-Barr

2022
Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
    Antimicrobial agents and chemotherapy, 2020, 03-24, Volume: 64, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Auranofin; Candida albicans; Candidiasis; Cell Line; Cic

2020
Case Report: Cryptococcal meningitis in Hodgkin's Lymphoma patient receiving brentuximab-vedotin therapy.
    F1000Research, 2020, Volume: 9

    Topics: Amphotericin B; Antifungal Agents; Brentuximab Vedotin; Cryptococcus neoformans; Dexamethasone; Fluc

2020
Case Report: Cryptococcal meningitis in Hodgkin's Lymphoma patient receiving brentuximab-vedotin therapy.
    F1000Research, 2020, Volume: 9

    Topics: Amphotericin B; Antifungal Agents; Brentuximab Vedotin; Cryptococcus neoformans; Dexamethasone; Fluc

2020
Case Report: Cryptococcal meningitis in Hodgkin's Lymphoma patient receiving brentuximab-vedotin therapy.
    F1000Research, 2020, Volume: 9

    Topics: Amphotericin B; Antifungal Agents; Brentuximab Vedotin; Cryptococcus neoformans; Dexamethasone; Fluc

2020
Case Report: Cryptococcal meningitis in Hodgkin's Lymphoma patient receiving brentuximab-vedotin therapy.
    F1000Research, 2020, Volume: 9

    Topics: Amphotericin B; Antifungal Agents; Brentuximab Vedotin; Cryptococcus neoformans; Dexamethasone; Fluc

2020
Multifocal muscle candidiasis of the legs in a patient with acute myeloid leukemia: A case report.
    Medicine, 2019, Volume: 98, Issue:8

    Topics: Abscess; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Candida tropicalis; Candidiasis;

2019
Favorable Evolution of Cryptococcal Meningitis in the Context of Flucytosine Resistance.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2018, Volume: 16, Issue:1

    Topics: Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Drug Substitution; Female; Fluc

2018
Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
    Revista iberoamericana de micologia, 2008, Dec-31, Volume: 25, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Brazil; Cross Infection; Dermatomycoses; Drug Resistance, Fungal;

2008
Cryptococcal infection in sarcoidosis.
    International journal of dermatology, 2002, Volume: 41, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Flucytosine; Humans; Mal

2002
Successful treatment of Trichosporon mucoides infection with lipid complex amphotericin B and 5-fluorocytosine.
    Mycoses, 2006, Volume: 49, Issue:3

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Male;

2006
Sarcoidosis as risk factor for cryptococcal meningitis in an apparently immunocompetent patient.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2008, Volume: 29, Issue:1

    Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fatal Outcome; Flucytosine; Human

2008
Cryptococcal meningitis in patients with glioma: a report of two cases.
    Journal of neuro-oncology, 2008, Volume: 89, Issue:1

    Topics: Adult; Aged; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Agents, Alk

2008
Successful antifungal treatment of disseminated candidiasis associated with ARDS.
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1993, Volume: 67, Issue:3

    Topics: Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Middle Aged; Oppor

1993
Cryptococcosis as an opportunistic infection in immunodeficiency secondary to paracoccidioidomycosis.
    Mycopathologia, 1996, Volume: 133, Issue:2

    Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Flucytosine; Humans; Immunologic Deficienc

1996
Cryptococcosis: an unusual opportunistic infection complicating B cell lymphoproliferative disorders.
    The Journal of infection, 1998, Volume: 36, Issue:2

    Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Female; Flucytos

1998
Successful cure of an extensive burn injury complicated with mucor wound sepsis.
    Burns : journal of the International Society for Burn Injuries, 1998, Volume: 24, Issue:1

    Topics: Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Body Surface Area; Burns; Debridemen

1998
Drugs for treatment of fungal infections.
    The Medical letter on drugs and therapeutics, 1992, Feb-21, Volume: 34, Issue:864

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole

1992
Treatment of cerebral aspergillosis after liver transplantation.
    Neurology, 1992, Volume: 42, Issue:9

    Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Brain Diseases; Combined Modality Therapy; Flu

1992
[Cryptococcosis: presentation of 26 cases].
    Medicina clinica, 1992, Mar-14, Volume: 98, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Aged, 80 and over; Amphotericin B; Antigens, Fungal

1992
Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease.
    The Journal of infectious diseases, 1992, Volume: 165, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combinat

1992
[Cryptococcosis in AIDS patients: a study of 19 cases].
    Revista clinica espanola, 1992, Volume: 190, Issue:9

    Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans;

1992
[Cryptococcal meningitis in AIDS: successful long-term prophylaxis with fluconazole].
    Deutsche medizinische Wochenschrift (1946), 1991, Dec-20, Volume: 116, Issue:51-52

    Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antigens, Bacterial; Cryptococcus; Drug T

1991
Fatal mucormycosis presenting as an appendiceal mass with metastatic spread to the liver during chemotherapy-induced granulocytopenia.
    Scandinavian journal of infectious diseases, 1990, Volume: 22, Issue:4

    Topics: Adult; Agranulocytosis; Amphotericin B; Appendix; Cecal Diseases; Female; Flucytosine; Humans; Injec

1990
First report of chronic meningitis caused by Trichosporon beigelii.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1990, Volume: 9, Issue:3

    Topics: Adolescent; Amphotericin B; Chronic Disease; Drug Therapy, Combination; Fluconazole; Flucytosine; Hu

1990
Cryptococcosis in AIDS patients: observations concerning CNS involvement.
    Journal of neurology, 1989, Volume: 236, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Male

1989
Cryptococcal meningitis in AIDS patients. A two-case report.
    Acta neurologica, 1988, Volume: 10, Issue:1 ||||||||

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Amphotericin B; Cryptococcosis; Drug Therapy,

1988
Drugs for treatment of deep fungal infection.
    The Medical letter on drugs and therapeutics, 1988, Mar-11, Volume: 30, Issue:761

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Humans; Ketoconazole; Mycoses; Op

1988
Successful treatment of disseminated Trichosporon beigelii (cutaneum) infection with associated splenic involvement.
    Cancer, 1986, Oct-15, Volume: 58, Issue:8

    Topics: Adult; Amphotericin B; Combined Modality Therapy; Flucytosine; Humans; Leukemia, Monocytic, Acute; M

1986
Candida infection in massively burned patients.
    The Journal of trauma, 1987, Volume: 27, Issue:10

    Topics: Amphotericin B; Anti-Bacterial Agents; Bacterial Infections; Burns; Candidiasis; Child; Flucytosine;

1987
Torulopsis glabrata infection in immunocompromised children.
    Southern medical journal, 1987, Volume: 80, Issue:2

    Topics: Amphotericin B; Candidiasis; Child; Child, Preschool; Drug Therapy, Combination; Female; Flucytosine

1987